MARKET

VBIV

VBIV

VBI Vaccines
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.280
-0.010
-0.78%
After Hours: 1.340 +0.06 +4.69% 19:23 01/24 EST
OPEN
1.350
PREV CLOSE
1.290
HIGH
1.400
LOW
1.230
VOLUME
4.39M
TURNOVER
--
52 WEEK HIGH
2.200
52 WEEK LOW
0.4655
MARKET CAP
228.17M
P/E (TTM)
-1.7942
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of VBIV and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

VBIV News

  • VBI Vaccines Regains Compliance with Nasdaq Minimum Bid Price Requirement
  • Business Wire.01/14 13:00
  • ACST, ADAP, SSI and VBIV among midday movers
  • Seeking Alpha - Article.01/13 17:39
  • DDD, NVTA among premarket gainers
  • Seeking Alpha - Article.01/13 14:27
  • SNCA, NBRV among premarket gainers
  • Seeking Alpha - Article.01/09 14:15

More

Industry

Biotechnology & Medical Research
-2.64%
Pharmaceuticals & Medical Research
-2.00%

Hot Stocks

Name
Price
%Change

About VBIV

VBI Vaccines Inc. is a development-stage biotechnology company. The Company's principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity. The Company's subsidiaries includes Variation Biotechnologies (US), Inc. (VBI US) and Variation Biotechnologies Inc. (VBI Cda).
More

Webull offers VBI Vaccines Inc (VBIV) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.